Cost Reduction Target self-funded employers by highlighting Regenexx Corporate Program's potential to reduce orthopedic healthcare costs by up to 70% through non-surgical, lower-cost alternatives to elective surgeries, and offer a compelling ROI case for mid-market and large employers.

Clinical Leadership Position Regenexx as a pioneer in regenerative orthopedics with extensive published research and a large network of physicians licensed to deliver the injectate solutions, leveraging credibility to win RFPs and payer negotiations.

Employer Reach Leverage the existing base of over 2,000 employer groups already offering the Regenexx benefit to expand into additional self-funded plans within industries with high orthopedic intervention rates, such as manufacturing, logistics, and healthcare.

Tech & Data Showcase the scalable technology stack and data capabilities (cloud, analytics, and security) to reassure employers about integration with their health plan systems, member experience, and compliance requirements.

Growth Momentum Highlight the sizable revenue opportunities indicated by current revenue bands and rapid expansion potential, presenting a near-term pipeline strategy focused on mid-market accounts and regional employer groups seeking non-surgical orthopedic solutions.